SOURCE: Metrasens


September 16, 2011 09:21 ET

Leading London 3T MRI Facility Opens With Safety Systems Provided by Metrasens Ferroguard

MALVERN, UNITED KINGDOM--(Marketwire - Sep 16, 2011) - Metrasens is pleased to announce the installation of its Ferroguard ferromagnetic detection system in the new 3T Magnetic Resonance Imaging (MRI) facility of the University College London Hospitals NHS Foundation Trust (UCLH). The new scanner, jointly funded by the UCLH/UCL Biomedical Research Centre (BRC) and UCLH, provides detailed, high definition images of tissue structures enabling scientists and clinicians to work together on translational research projects.

The opening of the new MRI facility marks a significant moment for UCLH and for the UCL Centre for Medical Imaging which has grown dramatically in the past year and leads on all radiology research at the hospital site. The new scanner will be shared jointly by clinical and research teams presenting additional challenges for protecting the imaging equipment investment and managing patient safety. In line with the latest recommendations and advice for managing MRI safety, Fiona Henderson, General Manager Clinical Services, and her team have installed Ferromagnetic Detectors developed and supplied by leading UK technology firm Metrasens to provide additional security for patients, staff, and protection for the scanner room itself from potentially hazardous ferromagnetic objects.

Dr. Stuart Taylor, Honorary Consultant Radiologist and Reader at UCL (University College London), commented, "We value the support and advice Metrasens provided during the installation works. The Metrasens Ferroguard System adds to the safe running of the 3T scanner and forms a key part of our safety processes at University College Hospital."

Dr. Simon Goodyear, CEO of Metrasens, stated, "Metrasens is proud to be associated with BRC and the UCL Centre for Medical Imaging. The fact that these leading institutes have recognised the importance of ferromagnetic detection as an integral part of this new facility is testament to increasing awareness by imaging centres of excellence around the world of the need to invest in superior safety technology to protect their patients, staff and imaging technology investment."

Notes for editors:

University College London Hospitals NHS Foundation Trust (UCLH), situated in the West End of London, is one of the largest NHS trusts in the United Kingdom and provides first-class acute and specialist services. University College Hospital, which opened in 2005, is the focal point of the trust alongside five cutting-edge specialist hospitals. The Trust is committed to research and development and forms part of UCL Partners which in March 2009 was officially designated as one of the UK's first academic health science centres by the Department of Health. UCLH works closely with UCL -- the seventh best university in the world in the Times Higher Education -- translating research into treatments for patients.

The UCLH/UCL Biomedical Research Centre (BRC), which was established in 2007, has invested in hundreds of different research projects. Funding provided by the BRC has attracted more than £90 million from external sources such as drug companies and charities who wish to undertake research.

Metrasens is provider of the Ferroguard range of ferromagnetic detection systems for protecting MRI facilities from the dangers of projectile accidents. The world-leading sensor technology in Ferroguard provides highest sensitivity resulting in greatest detection reliability. Metrasens is headquartered in the UK, has US sales and support facilities in Illinois and a growing network of international distribution partners. Metrasens' sophisticated magnetic detection core technologies are also being successfully employed in the rapidly growing worldwide security markets.

Contact Information

  • For more information contact
    +44 (0)1684 585285 (UK)
    630-863-7827 (USA)